AFib: Early Ablation Gets Dramatic Results, Cleveland Clinic Finds


Patients with atrial fibrillation do significantly better when catheter ablation is done quickly, Cleveland Clinic researchers found.

Patients with atrial fibrillation (AF) do significantly better when catheter ablation is done quickly, Cleveland Clinic researchers found. The patients who got earlier ablation showed less inflammation, hemodynamic strain, and atrial dilation (remodeling).

In a study published Jan. 13 in Circulation: Arrhythmia and Electrophysiology Ayman Hussein, MD, and colleagues assessed two-year outcomes for 1,241 patients undergoing first-time ablation for persistent AF. Patients with paroxysmal AF were excluded. Patients had to have failed at least one antiarrhythmic medication to be included in the study.

They gave patients echocardiograms and measured B-type natriuretic peptide and C-reactive protein before procedures. The median time between the patients’ getting a diagnosis of AF and having and ablation procedure was three years.

The procedure was done under an AF ablation protocol that involved continuing therapeutic anticoagulation. Doctors used a phased-array intravascular ultrasound catheter placed in the right atrium to assist with performing trans-septal punctures, guide catheter location and manipulation with then left atrium, and monitor for complications.

The end point of the procedures was complete isolation of the pulmonary veins and superior vena cava and demonstration of absence of LA triggers in sinus rhythm.

The team found that the longer patients waited to get the procedure, the poorer the outcome.

The researchers divided the study population using the time intervals between first persistent AF diagnosis and ablation. Those time quartiles were less than 1 year, 1.1 -3 years, 3.1-6.5 years, and more than 6.5 years.

The findings did not differ with patients’ age, sex, and risk factors for recurrence, the team found.

In those who had ablation within a year of persistent AF diagnosis, 33.6% had recurrence of arrhythmia. In those who the procedure within three years of diagnosis 52.6 % had recurrence of arrhythmia. If patients waited from 3.1 years to 6.5 years, the rate of recurrence of arrhythmia was 57.1%.

The percentage of patients who had a recurrence dropped slightly to 54.6% after 6.5 years.

“In patients with persistent AF undergoing ablation, the time interval between the first diagnosis and the catheter ablation procedure had a strong association with the ablation outcomes,” they concluded.

Shorter diagnosis-to-ablation times “were associated with better outcomes and in direct association with markers of atrial remodeling,” they noted.

The authors are hopeful that their study might change standard practice in treating persistent AF. The heart ailment affects about 2.7 million people in the US.

Related Videos
Video 6 - "Evaluating Safety of Novel LDL Management Mechanism"
Video 5 - "Optimizing PCSK9 Inhibitors and Analyzing Plaque Reduction Data"
Video 4 - "Innovations in Small Interfering RNA (siRNA) Therapy"
Video 3 - "Ongoing Lp(a) Trials and Clinical Approaches to Treatment"
Roger S. McIntyre, MD: GLP-1 Agonists for Psychiatry?
Payal Kohli, MD | Credit: Cherry Creek Heart
Matthew Nudy, MD | Credit: Penn State Health
Kelley Branch, MD, MSc | Credit: University of Washington Medicine
Kelley Branch, MD, MS | Credit: University of Washington Medicine
David Berg, MD, MPH | Credit: Brigham and Women's
© 2024 MJH Life Sciences

All rights reserved.